Latest News and Press Releases

Linthicum, MD, March 04, 2022 (GLOBE NEWSWIRE) --  NFM Lending is pleased to honor Combat Engineer and Army Specialist John Lanier, USA, as the NFM Salute for March 2022. Lanier was drafted in...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Biogen Inc. (“Biogen” or the “Company”) (NASDAQ: BIIB). Such investors are advised to...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Telos Corporation (“Telos” or the “Company”) (NYSE: TLS).   Such investors are advised to...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SunPower Corporation (“SunPower” or the “Company”) (NASDAQ: SPWR).   Such investors are...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of TaskUs, Inc. (“TaskUs” or the “Company”) (NASDAQ: TASK). Such investors are advised to...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Astra Space, Inc. f/k/a Holicity Inc. (“Astra Space” or the “Company”) (NASDAQ: ASTR).  ...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Pulse Biosciences, Inc. (“Pulse” or the “Company”) (NASDAQ: PLSE). Such investors are...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB). Such investors are...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Rhythm Pharmaceuticals, Inc. (“Rhythm” or the “Company”) (NASDAQ: RYTM). Such investors...

NEW YORK, March 04, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Gatos Silver, Inc. (“Gatos” or the “Company”) (NYSE: GATO).   Such investors are advised...